The Goldman Sachs Group, Inc. 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-06 2:52 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
GOLDMAN SACHS GROUP INC GS |
1,683,356 2.800% |
-2,833,221![]() (-62.73%) |
Filing |
2024-11-06 2:40 pm Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
GOLDMAN SACHS GROUP INC GS |
4,516,577 7.600% |
4,516,577![]() (New Position) |
Filing |